No Data
No Data
Qiming Medical-B (02500.HK): Zhu Bing appointed as Chief Financial Officer.
Gelonghui, September 9th: Qiming Medical-B (02500.HK) announced that Zhu Bing has been appointed as the company's Chief Financial Officer, effective from September 9, 2024.
Express News | Venus Medtech Hangzhou - Bing Zhu Appointed as CFO
A Quick Understanding: Announcement of Key Findings in the Review of Funds Usage for Qiming Medical-B (02500)
The stock has been suspended from trading on the Main Board of the Stock Exchange of Hong Kong since November 23, 2023. During this period, active communication with the Stock Exchange of Hong Kong has been conducted and a series of measures have been taken to meet the five resumption guidance, in order to resume trading of the company as soon as possible. The latest announcement on September 2 provides further disclosure on the progress of the first item of the five resumption guidance by the Stock Exchange of Hong Kong.
Express News | Venus Medtech Venus-Vitae Completes First Two Implantations in Smart-Align Pivotal Clinical Study
Leading the new generation of ball expansion aortic valve replacement (TAVR) | The first two patients successfully implanted with Venus-Vitae SMART-ALIGN international multi-center key clinical
Hangzhou, September 4, 2024 /PRNewswire/ - On August 30, 2024, Hangzhou Qiming Medical Instruments Co., Ltd. ("Qiming Medical", 02500.HK), China's leading innovative medical device platform for structural heart disease, announced that the first two patients who underwent the implantation of the self-developed next-generation Transcatheter Aortic Valve Replacement (TAVR) balloon-expandable valve system, Venus-Vitae, SMART-ALIGN, at the Prince of Wales Hospital in Hong Kong, were successful.
Qiming Medical-B (02500.HK): Li Yue resigns as a shareholder representative supervisor.
Bright Medical-B (02500.HK) announced on August 30th that (1) Ms. Li Yue has resigned as a shareholder representative supervisor of the company due to other matters. Her resignation will take effect from the appointment of a new shareholder representative supervisor at the temporary shareholders' meeting to be held by the company at the appropriate time; and (2) Ms. Shao Min has resigned as an employee representative supervisor and chairman of the company's board of supervisors due to other matters. Her resignation will take effect from the election of a new employee representative supervisor at the employee representative assembly to be held by the company on August 30, 2024. Mr. Zhang Changxi has been elected as an employee representative supervisor at the company's employee representative assembly. This election does not require approval from the shareholders. On the same day, the supervisory board
No Data